Use of antiepileptic drugs and risk of hypothyroidism

Pharmacoepidemiology and Drug Safety

Volumn 22, Issue 10, 2013, Pages 1071-1079

  Lai, Edward Chia Cheng ^a   Yang, Yea Huei Kao ^a   Lin, Swu Jane ^b   Hsieh, Cheng Yang ^a,c  

^a NATIONAL CHENG KUNG UNIVERSITY   (Taiwan)

^b UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

^c TAINAN SIN LAU HOSPITAL   (Taiwan)

Author keywords

Antiepileptic drugs; Drug safety; Hypothyroidism; Pharmacoepidemiology; Prescription sequence symmetry analysis

Indexed keywords

AMIODARONE; ANTICONVULSIVE AGENT; CARBAMAZEPINE; CLONAZEPAM; ETIRACETAM; GABAPENTIN; LAMOTRIGINE; OXCARBAZEPINE; PHENOBARBITAL; PHENYTOIN; PRIMIDONE; ROSUVASTATIN; THIAMAZOLE; THYROXINE; TIAGABINE; TOPIRAMATE; VALPROIC ACID; VIGABATRIN;

ANTICONVULSANT THERAPY; ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; DISEASE ASSOCIATION; DRUG USE; HUMAN; HYPOTHYROIDISM; MAJOR CLINICAL STUDY; OBSERVATIONAL STUDY; PRESCRIPTION; PRIORITY JOURNAL; RISK FACTOR; THYROID FUNCTION;

ANTIEPILEPTIC DRUGS; DRUG SAFETY; HYPOTHYROIDISM; PHARMACOEPIDEMIOLOGY; PRESCRIPTION SEQUENCE SYMMETRY ANALYSIS;

ANTICONVULSANTS; DATABASES, FACTUAL; EPILEPSY; HUMANS; HYPOTHYROIDISM; PHENYTOIN; RISK FACTORS; TAIWAN; TIME FACTORS;

EID: 84884979310     PISSN: 10538569     EISSN: 10991557     Source Type: Journal    
DOI: 10.1002/pds.3498     Document Type: Article

References (42)

1. Hsieh LP, Huang CY. Trends in the use of antiepileptic drugs in Taiwan from 2003 to 2007: a population-based national health insurance study. Epilepsy Res 2011; 96: 81-88.
2. Johannessen Landmark C, Larsson PG, Rytter E, et al. Antiepileptic drugs in epilepsy and other disorders--a population-based study of prescriptions. Epilepsy Res 2009; 87: 31-39.
3. Thvilum M, Brandt F, Brix TH, et al. A review of the evidence for and against increased mortality in hypothyroidism. Nat Rev Endocrinol 2012; 8(7): 417-424.
4. Rotondi M, Magri F, Chiovato L. Risk of coronary heart disease and mortality for adults with subclinical hypothyroidism. JAMA 2010; 304: 2481; author reply 2482.
5. Aygun F, Ekici B, Aydinli N, et al. Thyroid hormones in children on antiepileptic therapy. Int J Neurosci 2012; 122: 69-73.
6. Benedetti MS, Whomsley R, Baltes E, et al. Alteration of thyroid hormone homeostasis by antiepileptic drugs in humans: involvement of glucuronosyltransferase induction. Eur J Clin Pharmacol 2005; 61: 863-872.
7. Vainionpaa LK, Mikkonen K, Rattya J, et al. Thyroid function in girls with epilepsy with carbamazepine, oxcarbazepine, or valproate monotherapy and after withdrawal of medication. Epilepsia 2004; 45: 197-203.
8. Curran PG, DeGroot LJ. The effect of hepatic enzyme-inducing drugs on thyroid hormones and the thyroid gland. Endocr Rev 1991; 12: 135-150.
9. Franklyn JA, Sheppard MC, Ramsden DB. Measurement of free thyroid hormones in patients on long-term phenytoin therapy. Eur J Clin Pharmacol 1984; 26: 633-634.
10. Lossius MI, Tauboll E, Mowinckel P, et al. Reversible effects of antiepileptic drugs on thyroid hormones in men and women with epilepsy: a prospective randomized double-blind withdrawal study. Epilepsy Behav 2009; 16: 64-68.
11. Isojarvi JI, Airaksinen KE, Mustonen JN, et al. Thyroid and myocardial function after replacement of carbamazepine by oxcarbazepine. Epilepsia 1995; 36: 810-816.
12. Isojarvi JI, Turkka J, Pakarinen AJ, et al. Thyroid function in men taking carbamazepine, oxcarbazepine, or valproate for epilepsy. Epilepsia 2001; 42: 930-934.
13. Cansu A, Serdaroglu A, Camurdan O, et al. The evaluation of thyroid functions, thyroid antibodies, and thyroid volumes in children with epilepsy during short-term administration of oxcarbazepine and valproate. Epilepsia 2006; 47: 1855-1859.
14. Hirfanoglu T, Serdaroglu A, Camurdan O, et al. Thyroid function and volume in epileptic children using carbamazepine, oxcarbazepine and valproate. Pediatr Int 2007; 49: 822-826.
15. Verma NP, Haidukewych D. Differential but infrequent alterations of hepatic enzyme levels and thyroid hormone levels by anticonvulsant drugs. Arch Neurol 1994; 51: 381-384.
16. Cooper DS, Biondi B. Subclinical thyroid disease. Lancet 2012; 379: 1142-1154.
17. Pennell PB. Hormonal aspects of epilepsy. Neurol Clin 2009; 27: 941-965.
18. Jaja C, Burke W, Thummel K, et al. Cytochrome p450 enzyme polymorphism frequency in indigenous and native american populations: a systematic review. Community Genet 2008; 11: 141-149.
19. Brent GA. Environmental exposures and autoimmune thyroid disease. Thyroid 2010; 20: 755-761.
20. Taiwan Personal Information Protection Act http://law.moj.gov.tw/Eng/LawClass/LawContent.aspx?PCODE=I0050021 Accessed September 23, 2012.
21. National Health Insurance Research Database, Taiwan. http://nhird.nhri.org.tw/en/index.htm Accessed September 23, 2012.
22. Hallas J. Evidence of depression provoked by cardiovascular medication: a prescription sequence symmetry analysis. Epidemiology 1996; 7: 478-484.
23. Tsiropoulos I, Andersen M, Hallas J. Adverse events with use of antiepileptic drugs: a prescription and event symmetry analysis. Pharmacoepidemiol Drug Saf 2009; 18: 483-491.
24. Caughey GE, Roughead EE, Pratt N, et al. Increased risk of hip fracture in the elderly associated with prochlorperazine: is a prescribing cascade contributing? Pharmacoepidemiol Drug Saf 2010; 19: 977-982.
25. Garrison SR, Dormuth CR, Morrow RL, et al. Nocturnal leg cramps and prescription use that precedes them: a sequence symmetry analysis. Arch Intern Med 2012; 172: 120-126.
26. Maclure M. The case-crossover design: a method for studying transient effects on the risk of acute events. Am J Epidemiol 1991; 133: 144-153.
27. Leskiewicz M, Budziszewska B, Lason W. Endocrine effects of antiepileptic drugs. Przegl Lek 2008; 65: 795-798.
28. Capraro J, Thalmann S. Amiodarone and thyroid. Ther Umsch 2011; 68: 309-313.
29. Kostapanos MS, Milionis HJ, Elisaf MS. Rosuvastatin-associated adverse effects and drug-drug interactions in the clinical setting of dyslipidemia. Am J Cardiovasc Drugs 2010; 10: 11-28.
30. Morris JA, Gardner MJ. Calculating confidence intervals for relative risks (odds ratios) and standardised ratios and rates. Br Med J (Clin Res Ed) 1988; 296: 1313-1316.
31. Iervasi G, Clerico A, Bonini R, et al. Acute effects of amiodarone administration on thyroid function in patients with cardiac arrhythmia. J Clin Endocrinol Metab 1997; 82: 275-280.
32. Fichsel H, Knopfle G. Effects of anticonvulsant drugs on thyroid hormones in epileptic children. Epilepsia 1978; 19: 323-336.
33. Hansen JM, Skovsted L, Lauridsen UB, et al. The effect of diphenylhydantoin on thyroid function. J Clin Endocrinol Metab 1974; 39: 785-789.
34. Liewendahl K, Majuri H. Thyroxine, triiodothyronine, and thyrotropin in serum during long-term diphenylhydantoin therapy. Scand J Clin Lab Invest 1976; 36: 141-144.
35. Shorvon S. Oxcarbazepine: a review. Seizure 2000; 9: 75-79.
36. Eiris-Punal J, Del Rio-Garma M, Del Rio-Garma MC, et al. Long-term treatment of children with epilepsy with valproate or carbamazepine may cause subclinical hypothyroidism. Epilepsia 1999; 40: 1761-1766.
37. Gau CS, Chang CJ, Tsai FJ, et al. Association between mood stabilizers and hypothyroidism in patients with bipolar disorders: a nested, matched case-control study. Bipolar Disord 2010; 12: 253-263.
38. Verrotti A, Basciani F, Morresi S, et al. Thyroid hormones in epileptic children receiving carbamazepine and valproic acid. Pediatr Neurol 2001; 25: 43-46.
39. Adler JT, Hottinger DG, Kunnimalaiyaan M, et al. Inhibition of growth in medullary thyroid cancer cells with histone deacetylase inhibitors and lithium chloride. J Surg Res 2010; 159: 640-644.
40. Frye MA, Luckenbaugh D, Kimbrell TA, et al. Possible gabapentin-induced thyroiditis. J Clin Psychopharmacol 1999; 19: 94-95.
41. Hamed SA, Hamed EA, Kandil MR, et al. Serum thyroid hormone balance and lipid profile in patients with epilepsy. Epilepsy Res 2005; 66: 173-183.
42. Mazzaferri EL, Skillman TG. Diazepam (Valium) and thyroid function: a double-blind, placebo controlled study in normal volunteers showing no drug effect. Am J Med Sci 1969; 257: 388-394.